DUFU LIQUOR GP (00986): Dr. Liao Wenjian Appointed as Subsidiary CEO to Lead Company's RWA Business Division and Value Innovation Operations

Stock News
2025/09/12

DUFU LIQUOR GP (00986) announced that effective September 12, 2025, Dr. Liao Wenjian has been appointed as Chief Executive Officer of the company's subsidiary. He will be responsible for conducting feasibility studies on the proposed Real World Assets (RWA) and related digital assets business development, integration with the group's existing operations, and business development directions, as well as providing specific planning for related business expansion and implementation.

Dr. Liao Wenjian currently serves as Chairman of Blue Source Capital and Executive Dean of Beijing Blue Source National Industry Research Institute, with twenty years of deep experience in industry chain vertical investment, industry chain integration, and capital investment. Dr. Liao possesses extensive expertise in industrial research and capital operations, with profound insights into the development trends, policy directions, and market opportunities in the global Real World Assets tokenization (RWA) sector.

The company believes that Dr. Liao will leverage his substantial accumulation of relevant industrial resources and capital market operational experience to comprehensively lead the company's RWA business division and value innovation operations. This appointment aims to drive the company to become a professional service provider in the global Real World Assets tokenization (RWA) field, helping the company deepen its understanding and assist the group's future expansion in this sector.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10